Imatinib Mesylate | search
Click here to view Imatinib Mesylate news from 60+ newspapers.
Bookmark or Share- Imatinib: MedlinePlus Drug InformationImatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
- Imatinib - WikipediaIn July 1997, Novartis filed a new patent application in Switzerland on the beta crystalline form of imatinib mesylate (the mesylate salt of imatinib). The "beta crystalline form" of the molecule is a specific polymorph of imatinib mesylate; a specific way that the individual molecules pack together to form a solid.
- Imatinib Information for Patients - Drugs.comImatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer. Includes imatinib side effects, interactions, and indications.
- Imatinib (Oral Route) Description and Brand Names - Mayo ClinicDescriptions. Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent. Imatinib is used for these conditions: Aggressive systemic mastocytosis (ASM) Chronic eosinophilic leukemia (CEL)
- Imatinib: Uses, Interactions, Mechanism of Action | DrugBank OnlineImatinib mesylate is a protein-tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase, the constitutively active tyrosine kinase created by the Philadelphia chromosome abnormality in CML. 15 Although the function of normal BCR is still unclear, ABL activation is overexpressed in various tumors and is heavily implicated in cancer ...
More
